View Future GrowthPolisan Holding 과거 순이익 실적과거 기준 점검 0/6Polisan Holding 의 수입은 연평균 -29.5%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 5.6%의 비율로 증가했습니다. 매출은 연평균 18.9%의 비율로 증가해 왔습니다.핵심 정보-29.53%순이익 성장률-29.53%주당순이익(EPS) 성장률Chemicals 산업 성장률50.02%매출 성장률18.94%자기자본이익률-6.93%순이익률-16.50%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.Reported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.모든 업데이트 보기Recent updatesReported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).공고 • Apr 06Polisan Holding A.S., Annual General Meeting, Apr 30, 2026Polisan Holding A.S., Annual General Meeting, Apr 30, 2026. Location: dilovasi organize sanayi bolgesi, 1. kisim, liman caddesi, no:7, dilovasi, kocaeli TurkeyNew Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).Board Change • Apr 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Director Burcin Muftu was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.New Risk • Sep 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 91% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.New Risk • Jun 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₺2.91b (US$73.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₺2.91b market cap, or US$73.4m).Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (159% cash payout ratio). Share price has been volatile over the past 3 months (7.6% average weekly change).공고 • Mar 27Polisan Holding A.S., Annual General Meeting, Apr 28, 2025Polisan Holding A.S., Annual General Meeting, Apr 28, 2025. Location: dilovasi organize sanayi bolgesi, 1, kisim, liman caddesi, no:7, dilovasi, kocaeli TurkeyReported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₺11.94, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 285% over the past three years.Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.공고 • Sep 23Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Reported Earnings • Sep 06Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₺1.30b (up 14% from 2Q 2023). Net loss: ₺156.6m (down 270% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.공고 • Aug 22Polisan Holding A.S. to Report Q2, 2024 Results on Sep 05, 2024Polisan Holding A.S. announced that they will report Q2, 2024 results on Sep 05, 2024Reported Earnings • Jun 05First quarter 2024 earnings released: EPS: ₺0.25 (vs ₺0.016 in 1Q 2023)First quarter 2024 results: EPS: ₺0.25 (up from ₺0.016 in 1Q 2023). Revenue: ₺1.24b (up 20% from 1Q 2023). Net income: ₺186.6m (up ₺174.8m from 1Q 2023). Profit margin: 15% (up from 1.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth.공고 • May 22Polisan Holding A.S. to Report Q1, 2024 Results on Jun 03, 2024Polisan Holding A.S. announced that they will report Q1, 2024 results at 5:30 PM, GTB Standard Time on Jun 03, 2024Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. CEO & Executive Director Mehmet Hacikamiloglu was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Apr 02Full year 2023 earnings released: EPS: ₺0.99 (vs ₺2.15 in FY 2022)Full year 2023 results: EPS: ₺0.99 (down from ₺2.15 in FY 2022). Revenue: ₺5.60b (up 34% from FY 2022). Net income: ₺747.7m (down 54% from FY 2022). Profit margin: 13% (down from 39% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year whereas the company’s share price has increased by 67% per year.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₺15.32, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 23x in the Chemicals industry in Turkey. Total returns to shareholders of 388% over the past three years.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₺11.30, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 190% over the past three years.New Risk • Nov 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change).Valuation Update With 7 Day Price Move • Nov 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₺16.08, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 21x in the Chemicals industry in Turkey. Total returns to shareholders of 330% over the past three years.Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: ₺0.40 (vs ₺0.17 in 3Q 2022)Third quarter 2023 results: EPS: ₺0.40 (up from ₺0.17 in 3Q 2022). Revenue: ₺1.34b (up 11% from 3Q 2022). Net income: ₺305.9m (up 133% from 3Q 2022). Profit margin: 23% (up from 11% in 3Q 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺12.58, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 22x in the Chemicals industry in Turkey. Total returns to shareholders of 221% over the past three years.Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₺17.93, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 20x in the Chemicals industry in Turkey. Total returns to shareholders of 542% over the past three years.Reported Earnings • Aug 06Second quarter 2023 earnings released: EPS: ₺0.12 (vs ₺0.24 in 2Q 2022)Second quarter 2023 results: EPS: ₺0.12 (down from ₺0.24 in 2Q 2022). Revenue: ₺1.14b (flat on 2Q 2022). Net income: ₺92.1m (down 50% from 2Q 2022). Profit margin: 8.1% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₺8.63, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 208% over the past three years.Reported Earnings • May 07First quarter 2023 earnings released: EPS: ₺0.016 (vs ₺0.17 in 1Q 2022)First quarter 2023 results: EPS: ₺0.016 (down from ₺0.17 in 1Q 2022). Revenue: ₺1.03b (up 25% from 1Q 2022). Net income: ₺11.8m (down 91% from 1Q 2022). Profit margin: 1.1% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺9.53, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 10x in the Chemicals industry in Turkey. Total returns to shareholders of 310% over the past three years.Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).Reported Earnings • Mar 03Full year 2022 earnings released: EPS: ₺2.15 (vs ₺0.37 in FY 2021)Full year 2022 results: EPS: ₺2.15 (up from ₺0.37 in FY 2021). Revenue: ₺4.20b (up 113% from FY 2021). Net income: ₺1.63b (up 483% from FY 2021). Profit margin: 39% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₺9.27, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 222% over the past three years.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₺8.59, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 13x in the Chemicals industry in Turkey. Total returns to shareholders of 159% over the past three years.Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺11.66, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.Reported Earnings • Nov 02Third quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.06 in 3Q 2021)Third quarter 2022 results: EPS: ₺0.17 (up from ₺0.06 in 3Q 2021). Revenue: ₺1.22b (up 136% from 3Q 2021). Net income: ₺131.2m (up 190% from 3Q 2021). Profit margin: 11% (up from 8.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₺9.81, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺7.71, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 178% over the past three years.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₺6.79, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 213% over the past three years.Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: ₺0.24 (vs ₺0.054 in 2Q 2021)Second quarter 2022 results: EPS: ₺0.24 (up from ₺0.054 in 2Q 2021). Revenue: ₺1.14b (up 164% from 2Q 2021). Net income: ₺185.8m (up 355% from 2Q 2021). Profit margin: 16% (up from 9.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺5.65, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 15x in the Chemicals industry in Turkey. Total returns to shareholders of 156% over the past three years.Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺4.47, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 115% over the past three years.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₺3.63, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 17% over the past three years.Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.051 in 1Q 2021)First quarter 2022 results: EPS: ₺0.17 (up from ₺0.051 in 1Q 2021). Revenue: ₺826.1m (up 133% from 1Q 2021). Net income: ₺131.2m (up 238% from 1Q 2021). Profit margin: 16% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Esra Yazici was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).Reported Earnings • Mar 09Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₺0.37 (up from ₺0.17 in FY 2020). Revenue: ₺1.97b (up 87% from FY 2020). Net income: ₺279.9m (up 121% from FY 2020). Profit margin: 14% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 05Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₺515.2m (up 81% from 3Q 2020). Net income: ₺45.2m (up 168% from 3Q 2020). Profit margin: 8.8% (up from 5.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS ₺0.054 (vs ₺0.029 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₺431.1m (up 85% from 2Q 2020). Net income: ₺40.8m (up 85% from 2Q 2020). Profit margin: 9.5% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).Valuation Update With 7 Day Price Move • Mar 22Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺3.19, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 35x in the Chemicals industry in Turkey. Total returns to shareholders of 4.1% over the past three years.Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₺0.17 (vs ₺0.086 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₺1.05b (up 3.8% from FY 2019). Net income: ₺126.6m (up 94% from FY 2019). Profit margin: 12% (up from 6.4% in FY 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.Is New 90 Day High Low • Feb 24New 90-day low: ₺3.65The company is down 7.0% from its price of ₺3.92 on 26 November 2020. The Turkish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 65% over the same period.Is New 90 Day High Low • Jan 25New 90-day high: ₺4.32The company is up 17% from its price of ₺3.70 on 27 October 2020. The Turkish market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 64% over the same period.Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of ₺72.2m, up 64% from the prior year. Total revenue was ₺990.2m over the last 12 months, down 11% from the prior year.Is New 90 Day High Low • Oct 05New 90-day high: ₺3.38The company is up 3.0% from its price of ₺3.28 on 07 July 2020. The Turkish market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.매출 및 비용 세부 내역Polisan Holding가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이IBSE:POLHO 매출, 비용 및 순이익 (TRY Millions)날짜매출순이익일반관리비연구개발비31 Mar 266,124-1,01086211031 Dec 256,402-8898699230 Sep 255,557-6757837630 Jun 255,739-8687597431 Mar 257,083-9409349531 Dec 247,095-4229018730 Sep 247,3109159186630 Jun 247,3471,2518985731 Mar 247,8291,4448304831 Dec 238,0901,0807684730 Sep 2310,5121,6008145430 Jun 239,8811,6886744631 Mar 238,7221,9895524031 Dec 227,6122,1824212730 Sep 223,8466031651230 Jun 223,146517144931 Mar 222,440372126831 Dec 211,969280115730 Sep 211,602204102630 Jun 211,37217696631 Mar 211,17315786531 Dec 201,05112781530 Sep 209907281530 Jun 209679079631 Mar 201,0139381631 Dec 191,0136586530 Sep 191,1124459330 Jun 191,176-966431 Mar 191,169-1063331 Dec 181,1632855230 Sep 181,0176557330 Jun 1889010157231 Mar 1881510160231 Dec 177509957230 Sep 1769051370230 Jun 1760749954231 Mar 1752748439231 Dec 1647046936230 Sep 165746-38-430 Jun 1619823-16-131 Mar 163452314031 Dec 154342133130 Sep 15868201238양질의 수익: POLHO 은(는) 현재 수익성이 없습니다.이익 마진 증가: POLHO는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: POLHO은 수익성이 없으며 지난 5년 동안 손실이 연평균 29.5% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 POLHO의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: POLHO은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-9.3%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: POLHO는 현재 수익성이 없으므로 자본 수익률이 음수(-6.93%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/28 21:26종가2026/07/28 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Polisan Holding A.S.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kenan TuranYatirim Finansman Menkul Degerler A.S.
Reported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).
Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).
Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).
공고 • Apr 06Polisan Holding A.S., Annual General Meeting, Apr 30, 2026Polisan Holding A.S., Annual General Meeting, Apr 30, 2026. Location: dilovasi organize sanayi bolgesi, 1. kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey
New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
Board Change • Apr 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Director Burcin Muftu was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).
Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.
New Risk • Sep 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 91% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.
New Risk • Jun 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₺2.91b (US$73.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₺2.91b market cap, or US$73.4m).
Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.
New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (159% cash payout ratio). Share price has been volatile over the past 3 months (7.6% average weekly change).
공고 • Mar 27Polisan Holding A.S., Annual General Meeting, Apr 28, 2025Polisan Holding A.S., Annual General Meeting, Apr 28, 2025. Location: dilovasi organize sanayi bolgesi, 1, kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey
Reported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₺11.94, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 285% over the past three years.
Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.
공고 • Sep 23Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)
Reported Earnings • Sep 06Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₺1.30b (up 14% from 2Q 2023). Net loss: ₺156.6m (down 270% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.
공고 • Aug 22Polisan Holding A.S. to Report Q2, 2024 Results on Sep 05, 2024Polisan Holding A.S. announced that they will report Q2, 2024 results on Sep 05, 2024
Reported Earnings • Jun 05First quarter 2024 earnings released: EPS: ₺0.25 (vs ₺0.016 in 1Q 2023)First quarter 2024 results: EPS: ₺0.25 (up from ₺0.016 in 1Q 2023). Revenue: ₺1.24b (up 20% from 1Q 2023). Net income: ₺186.6m (up ₺174.8m from 1Q 2023). Profit margin: 15% (up from 1.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth.
공고 • May 22Polisan Holding A.S. to Report Q1, 2024 Results on Jun 03, 2024Polisan Holding A.S. announced that they will report Q1, 2024 results at 5:30 PM, GTB Standard Time on Jun 03, 2024
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. CEO & Executive Director Mehmet Hacikamiloglu was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Apr 02Full year 2023 earnings released: EPS: ₺0.99 (vs ₺2.15 in FY 2022)Full year 2023 results: EPS: ₺0.99 (down from ₺2.15 in FY 2022). Revenue: ₺5.60b (up 34% from FY 2022). Net income: ₺747.7m (down 54% from FY 2022). Profit margin: 13% (down from 39% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year whereas the company’s share price has increased by 67% per year.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₺15.32, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 23x in the Chemicals industry in Turkey. Total returns to shareholders of 388% over the past three years.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₺11.30, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 190% over the past three years.
New Risk • Nov 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change).
Valuation Update With 7 Day Price Move • Nov 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₺16.08, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 21x in the Chemicals industry in Turkey. Total returns to shareholders of 330% over the past three years.
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: ₺0.40 (vs ₺0.17 in 3Q 2022)Third quarter 2023 results: EPS: ₺0.40 (up from ₺0.17 in 3Q 2022). Revenue: ₺1.34b (up 11% from 3Q 2022). Net income: ₺305.9m (up 133% from 3Q 2022). Profit margin: 23% (up from 11% in 3Q 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺12.58, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 22x in the Chemicals industry in Turkey. Total returns to shareholders of 221% over the past three years.
Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₺17.93, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 20x in the Chemicals industry in Turkey. Total returns to shareholders of 542% over the past three years.
Reported Earnings • Aug 06Second quarter 2023 earnings released: EPS: ₺0.12 (vs ₺0.24 in 2Q 2022)Second quarter 2023 results: EPS: ₺0.12 (down from ₺0.24 in 2Q 2022). Revenue: ₺1.14b (flat on 2Q 2022). Net income: ₺92.1m (down 50% from 2Q 2022). Profit margin: 8.1% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₺8.63, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 208% over the past three years.
Reported Earnings • May 07First quarter 2023 earnings released: EPS: ₺0.016 (vs ₺0.17 in 1Q 2022)First quarter 2023 results: EPS: ₺0.016 (down from ₺0.17 in 1Q 2022). Revenue: ₺1.03b (up 25% from 1Q 2022). Net income: ₺11.8m (down 91% from 1Q 2022). Profit margin: 1.1% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺9.53, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 10x in the Chemicals industry in Turkey. Total returns to shareholders of 310% over the past three years.
Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).
Reported Earnings • Mar 03Full year 2022 earnings released: EPS: ₺2.15 (vs ₺0.37 in FY 2021)Full year 2022 results: EPS: ₺2.15 (up from ₺0.37 in FY 2021). Revenue: ₺4.20b (up 113% from FY 2021). Net income: ₺1.63b (up 483% from FY 2021). Profit margin: 39% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₺9.27, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 222% over the past three years.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₺8.59, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 13x in the Chemicals industry in Turkey. Total returns to shareholders of 159% over the past three years.
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺11.66, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.
Reported Earnings • Nov 02Third quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.06 in 3Q 2021)Third quarter 2022 results: EPS: ₺0.17 (up from ₺0.06 in 3Q 2021). Revenue: ₺1.22b (up 136% from 3Q 2021). Net income: ₺131.2m (up 190% from 3Q 2021). Profit margin: 11% (up from 8.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₺9.81, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.
Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺7.71, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 178% over the past three years.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₺6.79, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 213% over the past three years.
Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: ₺0.24 (vs ₺0.054 in 2Q 2021)Second quarter 2022 results: EPS: ₺0.24 (up from ₺0.054 in 2Q 2021). Revenue: ₺1.14b (up 164% from 2Q 2021). Net income: ₺185.8m (up 355% from 2Q 2021). Profit margin: 16% (up from 9.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺5.65, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 15x in the Chemicals industry in Turkey. Total returns to shareholders of 156% over the past three years.
Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺4.47, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 115% over the past three years.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₺3.63, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 17% over the past three years.
Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.051 in 1Q 2021)First quarter 2022 results: EPS: ₺0.17 (up from ₺0.051 in 1Q 2021). Revenue: ₺826.1m (up 133% from 1Q 2021). Net income: ₺131.2m (up 238% from 1Q 2021). Profit margin: 16% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Esra Yazici was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).
Reported Earnings • Mar 09Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₺0.37 (up from ₺0.17 in FY 2020). Revenue: ₺1.97b (up 87% from FY 2020). Net income: ₺279.9m (up 121% from FY 2020). Profit margin: 14% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 05Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₺515.2m (up 81% from 3Q 2020). Net income: ₺45.2m (up 168% from 3Q 2020). Profit margin: 8.8% (up from 5.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS ₺0.054 (vs ₺0.029 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₺431.1m (up 85% from 2Q 2020). Net income: ₺40.8m (up 85% from 2Q 2020). Profit margin: 9.5% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺3.19, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 35x in the Chemicals industry in Turkey. Total returns to shareholders of 4.1% over the past three years.
Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₺0.17 (vs ₺0.086 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₺1.05b (up 3.8% from FY 2019). Net income: ₺126.6m (up 94% from FY 2019). Profit margin: 12% (up from 6.4% in FY 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.
Is New 90 Day High Low • Feb 24New 90-day low: ₺3.65The company is down 7.0% from its price of ₺3.92 on 26 November 2020. The Turkish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 65% over the same period.
Is New 90 Day High Low • Jan 25New 90-day high: ₺4.32The company is up 17% from its price of ₺3.70 on 27 October 2020. The Turkish market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 64% over the same period.
Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of ₺72.2m, up 64% from the prior year. Total revenue was ₺990.2m over the last 12 months, down 11% from the prior year.
Is New 90 Day High Low • Oct 05New 90-day high: ₺3.38The company is up 3.0% from its price of ₺3.28 on 07 July 2020. The Turkish market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.